Monday, June 22, 2026
← Back to archivePolicy
Policy•Fierce Biotech•Jun 19, 2026

FDA warning slams Zoll Medical with multiple quality control and reporting violations
background ▾
- •FDA warning slams Zoll Medical with multiple quality control and reporting violations
Policy•Fierce Biotech•Jun 22, 2026

Insilico lands heavily backloaded $2.5B AI drug discovery deal with SK Biopharm
background ▾
- •Insilico lands heavily backloaded $2.5B AI drug discovery deal with SK Biopharm
Policy•Fierce Biotech•Jun 22, 2026

FDA Breakthrough Therapy and RMAT: Strategic Decisions That Can Accelerate Oncology Development
background ▾
- •FDA Breakthrough Therapy and RMAT: Strategic Decisions That Can Accelerate Oncology Development
Policy•Fierce Biotech•Jun 22, 2026

How data-driven diagnostic lab services drive precise clinical trial enrollment
background ▾
- •How data-driven diagnostic lab services drive precise clinical trial enrollment
Policy•Fierce Biotech•Jun 22, 2026

Redefining what success looks like in PSC: The evolution of clinical trial endpoints
background ▾
- •Redefining what success looks like in PSC: The evolution of clinical trial endpoints
Market Access
No articles for this category on this date.
Clinical Trials
No articles for this category on this date.